Clinical Trials Sponsored by Algorithme Pharma Inc
Total 2359 results
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
CM Chungmu HospitalKorea United Pharm. Inc.UnknownNausea | VomitingKorea, Republic of
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Astellas Pharma Inc; Medivation, Inc.Active, not recruitingAdenocarcinoma of the ProstateUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States
-
Darma Inc.Virginia Commonwealth UniversityCompletedVital Sign MonitoringUnited States
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaUnited States, Japan, Korea, Republic of, Taiwan, Spain, Italy, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Greece, New Zealand, Poland
-
Faes Farma, S.A.ORA, Inc.CompletedAllergic ConjunctivitisUnited States
-
Universidad de los Andes, ChileGeistlich Pharma AG; BioHorizons, Inc.RecruitingAlveolar Ridge EnlargementChile
-
University of Illinois at ChicagoMitsubishi Tanabe Pharma America Inc.RecruitingAmyotrophic Lateral SclerosisUnited States
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.Oyster Point Pharma, Inc.Completed
-
Enyo PharmaParexel; Novotech (Australia) Pty Limited; Synteract, Inc.; EurofinsTerminatedHepatitis B, ChronicAustralia, Hong Kong, Korea, Republic of, Poland
-
MEDA Pharma GmbH & Co. KGSanofi; ClinResearch, GmbHCompletedAsthma, Exercise-InducedGermany
-
Teva Pharma GmbHCompleted
-
EIP Pharma IncAmsterdam UMC, location VUmc; Worldwide Clinical TrialsCompletedAlzheimer DiseaseUnited States, Netherlands, United Kingdom, Czechia, Denmark
-
University of Texas Southwestern Medical CenterAstellas Pharma US, Inc.CompletedProstate CancerUnited States
-
US Oncology ResearchBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedColorectal Neoplasms | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
Institut für Pharmakologie und Präventive MedizinPharma Medica Research, Inc.CompletedFever | Pain, Acute | Pain, Back | Pain, HeadCanada
-
NYU Langone HealthBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedneurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade GliomaUnited States
-
Norman MuirheadAstellas Pharma Canada, Inc.Completed
-
Faes Farma, S.A.ORA, Inc.CompletedAllergic ConjunctivitisUnited States
-
Darma Inc.Tufts Medical CenterCompletedVital Sign MonitoringUnited States
-
Institut de Recherches Cliniques de MontrealPharmascience Inc.; SCiAN Services, Inc.; Quercis Pharma AGNot yet recruiting
-
Sawa Ito, MDHorizon Pharma USA, Inc.CompletedMyelodysplastic Syndromes | Myeloid Leukemia | Allogeneic Stem Cell TransplantationUnited States
-
EA Pharma Co., Ltd.Kissei Pharmaceutical Co., Ltd.CompletedA Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative ColitisColitis, UlcerativeJapan
-
Cleveland Clinic FloridaAstellas Pharma US, Inc.Terminated
-
Teva Pharma GmbHCompletedPatient SatisfactionGermany
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Linical KoreaNational Cancer Center, Korea; Astellas Pharma Korea, Inc.Completed
-
Radboud University Medical CenterAstellas Pharma Inc; St. Antonius HospitalCompleted
-
Ranjan DohilMeritage Pharma, Inc.CompletedEosinophilic EsophagitisUnited States
-
St. Louis UniversityAstellas Pharma US, Inc.; University of FloridaCompletedCoronary Artery DiseaseUnited States
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
AZTherapies, Inc.Pharma Consulting Group AB; KCAS; Panax Clinical ResearchCompletedHealthy VolunteersUnited States
-
RenJi HospitalNitto Denko Corporation; Giant Med-Pharma Services Inc.UnknownWe Focus on the Pain of Venipuncture and Intravenous CannulationChina
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
University of WashingtonBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedHepatocellular Carcinoma
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.Active, not recruitingSalivary CancerUnited States
-
Aneira Pharma, Inc.DataPharm Australia, CMAX Clinical Research, Agilex AustraliaNot yet recruiting
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
University of Michigan Rogel Cancer CenterAscentage Pharma Group Inc.Active, not recruitingSalivary Gland Cancer | Malignant Salivary Gland CancerUnited States
-
Attune Health Research, Inc.Horizon Pharma Ireland, Ltd., Dublin IrelandActive, not recruiting
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
University of North Carolina, Chapel HillAstellas Pharma US, Inc.Completed
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.Oyster Point Pharma, Inc.Completed
-
Tris Pharma, Inc.Massachusetts General Hospital; Massachusetts Institute of TechnologyCompleted
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Daniel Burdick, MDAstellas Pharma US, Inc.Completed